Development
Cytokinetics, Incorporated
CYTK
$35.14
-$1.02-2.82%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -21.44% | -37.85% | -3.46% | 9.03% | 65.93% |
| Total Receivables | 772.79% | 8.94% | -50.08% | -83.39% | -99.74% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -4.16% | 37.44% | 36.78% | 65.50% | 72.72% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -21.02% | -36.51% | -2.60% | 9.16% | 48.45% |
|
|
|||||
| Total Current Assets | -21.02% | -36.51% | -2.60% | 9.16% | 48.45% |
| Net Property, Plant & Equipment | -9.47% | 0.11% | 4.89% | 8.27% | 11.46% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -17.49% | 5.45% | 3.56% | 11.86% | 34.82% |
| Total Assets | -18.77% | -31.17% | 1.06% | 3.92% | 20.62% |
|
|
|||||
| Total Accounts Payable | -16.02% | -4.39% | -10.78% | -12.50% | 21.45% |
| Total Accrued Expenses | -3.30% | -18.08% | -14.26% | 20.88% | 28.30% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 110.13% | 1.06% | 2.14% | -7.32% | -7.24% |
| Total Finance Division Other Current Liabilities | 751.20% | 187.26% | 751.66% | 271.64% | -27.08% |
| Total Other Current Liabilities | 751.20% | 187.26% | 751.66% | 271.64% | -27.08% |
| Total Current Liabilities | 21.34% | 1.60% | -1.83% | 12.53% | 17.75% |
|
|
|||||
| Total Current Liabilities | 21.34% | 1.60% | -1.83% | 12.53% | 17.75% |
| Long-Term Debt | -0.37% | 0.08% | 209.50% | 212.06% | 326.79% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -4.98% | 6.07% | 9.04% | 11.26% | 13.07% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 26.02% | 27.03% | 10.93% | -15.73% | 11.46% |
| Total Liabilities | 7.84% | 8.01% | 68.56% | 51.20% | 87.91% |
|
|
|||||
| Common Stock & APIC | 16.48% | 6.90% | 6.47% | 5.94% | 2.02% |
| Retained Earnings | -33.18% | -36.36% | -41.31% | -33.49% | -31.33% |
| Treasury Stock & Other | 99.72% | 84.28% | 67.56% | 54.17% | -313.12% |
| Total Common Equity | -258.04% | -2,646.45% | -398.99% | -296.99% | -144.25% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -258.04% | -2,646.45% | -398.99% | -296.99% | -144.25% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -258.04% | -2,646.45% | -398.99% | -296.99% | -144.25% |
|
|
|||||